Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC UK Licence No: PL 00289/2116 Teva UK Limited PAR Liothyronine Sodium 20 microgram Tablets UK/H/6516/001/DC 2 LAY SUMMARY Liothyronine Sodium 20 microgram Tablets (liothyronine sodium) This is a summary of the Public Assessment Report (PAR) for Liothyronine Sodium 20 microgram Tablets (PL 00289/2116; UK/H/6516/001/DC). It explains how Liothyronine Sodium 20 microgram Tablets were assessed and their authorisation recommended as well as their conditions of use.
Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}